| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 86.27▲ | 86.13▲ | 85.94▲ | 86.31▲ | 83.45▲ |
| MA10 | 86.28▲ | 85.81▲ | 85.99▲ | 86.93▼ | 79.92▲ |
| MA20 | 86.10▲ | 86.00▲ | 85.98▲ | 84.22▲ | 74.29▲ |
| MA50 | 85.88▲ | 85.94▲ | 86.88▼ | 79.25▲ | 66.66▲ |
| MA100 | 86.05▲ | 87.06▼ | 86.30▲ | 73.96▲ | 66.01▲ |
| MA200 | 85.98▲ | 85.73▲ | 81.79▲ | 67.75▲ | 51.52▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.078▲ | 0.085▲ | -0.224▼ | 1.351▲ |
| RSI | 60.100▲ | 53.648▲ | 50.961▲ | 57.437▲ | 64.244▲ |
| STOCH | 61.034 | 70.439 | 42.116 | 40.076 | 77.590 |
| WILL %R | -53.488 | -22.330▲ | -36.128 | -39.784 | -16.075▲ |
| CCI | 147.730▲ | 116.925▲ | 76.795 | -18.655 | 122.397▲ |
|
Thursday, September 03, 2026 04:59 AM
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 84.57 | 86.81 | 84.1505 | 86.53 | 182,180 |
| 03/09/26 | 86.83 | 88.26 | 85.20 | 86.09 | 258,411 |
| 02/09/26 | 85.34 | 86.75 | 84.72 | 85.50 | 272,716 |
| 01/09/26 | 89.03 | 89.03 | 84.15 | 85.84 | 257,533 |
| 31/08/26 | 88.08 | 88.71 | 86.8301 | 87.58 | 150,209 |
| 28/08/26 | 89.68 | 89.9999 | 86.58 | 86.94 | 171,191 |
| 27/08/26 | 88.37 | 89.73 | 87.38 | 89.22 | 168,905 |
| 26/08/26 | 86.38 | 90.9299 | 86.25 | 88.59 | 295,684 |
| 25/08/26 | 86.23 | 87.0075 | 85.35 | 85.94 | 251,405 |
| 24/08/26 | 88.50 | 89.03 | 85.73 | 87.05 | 342,744 |
|
|
||||
|
|
||||
|
|